Managed Care

 

Insurers lean toward generic alternatives

MANAGED CARE December 2007. © MediMedia USA
The Formulary Files

Insurers lean toward generic alternatives

MANAGED CARE December 2007. ©MediMedia USA













Insurers have traditionally focused their attention on savings through therapeutic equivalents, which contain the same active ingredients, strength, and dosage form as the original brand-name drug. But, according to an article published in the British Journal of Generic Medicines titled “Maximising Generic Utilization: The Power of Pharmacy Benefit Management,” more insurers are focusing their attention on a second approach to generic drug management — generic alternatives, which contain different active ingredients, but have comparable efficacy to brand-name drugs in the same class. For example, some plans may encourage the use of generic omeprazole as a therapeutic alternative to patent-protected brands in the proton pump inhibitor class.

In 2006, brand-name drugs accounted for about 42 percent of total dispensing volume, according to Medco Health Solutions. About 9 percent of the current dispensing volume could be converted to therapeutic equivalents over the next three years. An additional 11 percent to 16 percent of current dispensing could be converted to generics because new generics expand the range of treatment options. High-priced brands are the best candidates to switch because the large cost differentials are an incentive for payers and members to change therapy.

Source: Snow, DB. 2007. J Generic Medicines. 5:27–38.

Meetings

2014 Annual HEDIS® and Star Ratings Symposium Nashville, TN November 3–4, 2014
PCMH & Shared Savings ACO Leadership Summit Nashville, TN November 3–4, 2014
Medicare Risk Adjustment, Revenue Management, & Star Ratings Fort Lauderdale, FL November 12–14, 2014
World Orphan Drug Congress Europe 2014 Brussels, Belgium November 12–14, 2014
Healthcare Chief Medical Officer Forum Alexandria, VA November 13–14, 2014
Home Care Leadership Summit Atlanta, GA November 17–18, 2014
6th Semi-Annual Diagnostic Coverage and Reimbursement Conference Boston December 4–5, 2014
Customer Analytics & Engagement in Health Insurance Chicago December 4–5, 2014
Pharmaceutical and Biotech Clinical Quality Assurance Conference Alexandria, VA December 4–5, 2014
9th Semi-Annual Medical Device Coverage and Reimbursement Conference San Diego December 5, 2014
8th Annual Medical Device Clinical Trials Conference Chicago December 8–9, 2014
HealthIMPACT Southeast Tampa, FL January 23, 2015